Johnson & Johnson said the booster generated a “rapid and robust” increase in antibodies nine times higher than seen four weeks after the vaccine’s first and only dose was given.
Category: Editors’ Pick
Vaccine Protection Wanes Within Six Months Of Second Covid Shot, Study Warns, But They’re Still Effective Against Delta
The Pfizer shot was 88% effective at preventing infection a month after the second dose, but that fell to 74% after five to six months, the study found.
Will FDA Approval Increase Covid-19 Vaccination? That Depends On These 3 Things
Dr. Joshua Liao discusses how we should use FDA approval to approach people with empathy and humility, not as a bludgeon in vaccine communication.
Indian Government Authorizes Needle-Free Covid Vaccine
The DNA vaccine, developed by Indian company Zydus Cadila, is the second Indian-developed Covid vaccine to get a regulatory thumbs up.
To Get Everyone Vaccinated, The United States Needs A National Vaccination Corps
Health policy experts Lawrence Gostin and Eric Friedman explain how the federal government can step up and get more people vaccinated.
U.S. Satisfaction Hits Record Low In Biden Presidency Amid Delta Surge, Poll Finds—But Republicans Still Don’t View Covid As Major Threat
Democrats and Independents are increasingly worried about the threat of Covid-19 to the country while Republicans, practically no more concerned about the coronavirus than they were last month, are more concerned about immigration and the government.
Pfizer Received Full FDA Approval For Its Covid Vaccine: Here’s What’s Next
On Monday, the Food and Drug Administration granted full approval for Pfzer/BioNTech’s Covid-19 vaccine, now marketed under the name Comirnaty, for everyone aged 16 and up.
Unvaccinated Covid Patients Cost U.S. Health System Billions — And They’re Not The Ones Paying For It
Taxpayers, businesses and workers will be paying back some $2.3 billion in Covid-19 hospital expenses from June and July alone that could have been easily prevented with vaccination, new research suggests.
Why We Need To Change How We Talk About Covid-19 Vaccines
Dr. Joshua Liao discusses how framing can be used to combat over-optimism about vaccination, which contributed to premature decisions to drop masking and social distancing requirements and public confusion.
The Success Of Covid-19 Vaccines Should Be Measured By Hospitalization Rates, Not Infection Rates
Dr. Matt Binnicker, an expert in the diagnosis of infectious diseases, explains why hospitalization rates are the key metric against which to measure the success of Covid-19 vaccines.
